A long time awaited 55ml Vitastem spray’s approval from FDA finally occurred. The company can distribute the spray to multiple hospitals, clinics, and drug stores to provide a soliton for large injuries.
As the analgesics market in the U.S is almost $12 billion dollars offering new Liberdol for pain relief purposes has opened a bright opportunity to diversify the revenue soon.
The management anticipates 500 000 units of sales in 2021
The upside move is likely because of the company outlook for 2021. In the release, ViaDerma acknowledged that 2020 was a strong year. It launched a new pain relief product, secured further financing and saw large-scale potential clients test its signature Vitastem.
News 
Market Data 
Discover 
